Privat
Alain Privat, St Clement De Riviere FR
Patent application number | Description | Published |
---|---|---|
20100098664 | Lentiviral vectors allowing RNAi mediated inhibition of GFAP and vimentin expression - The present invention relates to method for preventing, treating or alleviating a central nervous system (CNS) disorder using a non replicative lentivirus comprising a lentiviral genome comprising a nucleic acid sequence producing at least one functional miRNA, at least one functional shRNA and/or at least one functional siRNA, preferably derived from said shRNA, said miRNA, shRNA or siRNA being designed to silence the expression of a gene that encodes a protein of the astrocyte cytoskeleton. The present invention further relates to compositions and kits comprising such a lentivirus as well as to uses thereof. | 04-22-2010 |
Eric Privat, Gennevilliers FR
Patent application number | Description | Published |
---|---|---|
20150156734 | SATELLITE COMMUNICATION DEVICE, SATELLITE COMMUNICATION SYSTEM COMPRISING SUCH A DEVICE AND METHOD FOR MANAGING THE RESOURCES ALLOCATED WITHIN SUCH A SYSTEM - In the field of satellite communication systems, a method is provided for managing communication resources allocated by central control equipment to the various terminal communication devices within a global satellite communication system. In particular, the management of communication resources by way of the monitoring of the equivalent isotropically radiated power transmitted by a terminal of the satellite communication system is provided. | 06-04-2015 |
Guillaume Privat, Oakland, CA US
Patent application number | Description | Published |
---|---|---|
20140040360 | METHODS AND SYSTEMS FOR ESTABLISHING, HOSTING AND MANAGING A SCREEN SHARING SESSION INVOLVING A VIRTUAL ENVIRONMENT - Techniques for establishing a screen sharing session are described. Consistent with some embodiments, a web conferencing application executing at a mobile computing device enables a user to specify the identity of a remote computer. The identity of the remote computer is communicated to a web conferencing service, directing the server operating the web conferencing service to establish a remote desktop connection with the remote computer. Once established, the web conferencing service receives from the remote computer a stream of information representing a user interface of the remote computer, and then broadcasts the user interface to all computing devices participating in the web conferencing session, while enabling the mobile computing device to manipulate the user interface of the remote computer. | 02-06-2014 |
Isabelle Privat, Tours FR
Patent application number | Description | Published |
---|---|---|
20100154074 | Nucleic Acids and Proteins Associated with Sucrose Degradation in Coffee - Disclosed herein are nucleic acid molecules isolated from coffee ( | 06-17-2010 |
Isabelle M. Privat, Saint Pierre De Corps FR
Patent application number | Description | Published |
---|---|---|
20120060235 | NUCLEIC ACIDS AND PROTEINS ASSOCIATED WITH SUCROSE ACCUMULATION IN COFFEE - Disclosed herein are nucleic acid molecules isolated from coffee ( | 03-08-2012 |
Maud Privat, Clermont-Ferrand FR
Patent application number | Description | Published |
---|---|---|
20130143753 | METHODS FOR PREDICTING OUTCOME OF BREAST CANCER, AND/OR RISK OF RELAPSE, RESPONSE OR SURVIVAL OF A PATIENT SUFFERING THEREFROM - The present invention relates to biomarkers allowing predicting breast tumor and solid tumor outcome using hypoxia related genes. More specifically, the present invention relates to a method for predicting the survival of a patient suffering from cancer, said method comprising the steps of (a) measuring the expression of at least five genes selected from the group consisting of GLUT1, PGK1, LDHA, ENO1, CAIX, NHERF1, TPI, AMF/GPI, VEGFA, TGFB3, ENG, LEP, EDN1, MDR1, AK3, MXR1, TGM2, CDH1, MMP2, CK1 9, VIM, CXCR4, UPAR, CATHD, CTGF, C0X2, MET, IGF-2, CCND1, EPO, NDRG1, BNIP3, NIX, ETS1, PHD2, TWIST1, DEC1, SNAH, CEBPA, CITED2, F0X03A, NUR77, BRCA1, PTEN, VHL and ERBB2 in a biological sample of said patient, and (b) analyzing the expression values to generate a risk score of relapse, wherein a risk score superior or equal to three is indicative of high risk of relapse and a risk score inferior or equal to two is indicative of a low risk of relapse. In particular the following genes: EPO, ETS1, ENO1, PGK1, LDHA, TPI and optionally VEGFA were significantly over-expressed in patients with relapse. | 06-06-2013 |
Michel Privat, Caignac FR
Patent application number | Description | Published |
---|---|---|
20090295523 | Rotating Transformer - The transformer ensures the transmission of electrical power by electromagnetic induction between the first ( | 12-03-2009 |
Patricia Privat, Magny-Les-Hameaux FR
Patent application number | Description | Published |
---|---|---|
20140007595 | PROCESS FOR THE MANUFACTURE OF A MIXTURE OF LIQUID NITROGEN AND LIQUID OXYGEN, THE PROPORTIONS OF WHICH ARE APPROXIMATELY THOSE OF LIQUID AIR - The invention relates to a process for the manufacture of a mixture of liquid nitrogen and liquid oxygen, the proportions of which are approximately those of liquid air, according to which: | 01-09-2014 |
Sylvie Privat, Burlingame, CA US
Patent application number | Description | Published |
---|---|---|
20090118133 | BIOLOGICAL DATASET PROFILING OF CARDIOVASCULAR DISEASE AND CARDIOVASCULAR INFLAMMATION - Methods and systems for evaluating biological dataset profiles relating to inflammatory cardiovascular conditions are provided, where datasets comprising information for multiple cellular parameters are compared and identified, and used in the evaluation of candidate pharmacologic agents for suitability as therapeutic agents. | 05-07-2009 |